BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

MAXOR NATIONAL PHARMACY SERVICES CORP — Receipts Report

LD-2 disclosure · 4th Quarter - Termination (No Activity)

MAXOR NATIONAL PHARMACY SERVICES CORP

via DA VINCI GROUP

4th Quarter (Oct 1 - Dec 31) · 2010Posted Sept 1, 2011Filing document ↗LDA record ↗

Income$60Kfee reported

Client

Name: MAXOR NATIONAL PHARMACY SERVICES CORP
Description: Healthcare
Location: Texas · United States of America

Registrant

Firm: DA VINCI GROUP
Description: Government Affairs Firm
Location: Purcellville, Virginia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.